Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 08, 2019 4:10pm
132 Views
Post# 29809157

RE:RE:RE:RE:RE:RE:RE:Tick Tock, 37 days left on 90 day clock

RE:RE:RE:RE:RE:RE:RE:Tick Tock, 37 days left on 90 day clock
40Baggs wrote: If APHA could sell 25-30M shares at $10-13 to a big name and they bring in a CEO, we would test ATH's by October. Irwin seems more aware of the market forces then past mgmt ever was.


bionicjoe wrote: I've given up for the most part reading and posting positve links. The market simply doesn't care. I've come to accept that what will draw the attention of the market is a JV with a major multinational which can happen at any time or failing that, the traditional route of growing your revenue through increased sales to the point where the company is profitable. If you want a quick boost to the sp that will stand up to the emotions that prevail in this sector, the JV choice is the better option since it will stabilize the sp at a much higher level. What has Cronus done to impress yet its sp is $21.


 




The thing is we don't know what Aphria's strategy is going forward. Simon has yet to show us his cards. Will he go the Aurora route and look for JV deals with multiple partners or is he interested in courting 1 large investor to take a substantial piece of the company? Or is he open to all options? In my mind if he chooses to go with multiple partners they have to be well known heavyweights in their particular sectors or else the good effects from the news will quickly evaporate. It can't be deals signed with fringe players that just want to put their toe in the water but they must commit to spend large sums of money if we are to see any benefit to the sp. IMO, Simon has done an admiral job of regaining respect for Aphria at the corporate level but his work is far from over. He and the BOD still have to show that they are capable of guiding Aphria to higher valuations. A sp in the mid 9's doesn't excite me given what it used to be not too long ago. Shareholders will be looking to him this summer to bring a more positive outlook to our financial positions. It's all about the money as they say. Hope he doesn't disappoint.

Bullboard Posts